Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
18.11.25
/
50%
€155.95
Target price
18.11.26
€202.73
Performance (%)
6.16%
Price
10.04.26
€165.55
Summary
This prediction is currently active. With a performance of 6.16%, the BUY prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc is trending in the right direction. This prediction currently runs until 18.11.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 2.191% | 2.191% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Wells Fargo & Company from $170.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€162.75
25.02.26
25.02.26
€212.10
25.02.27
25.02.27
1.72%
10.04.26
10.04.26
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.00
13.02.25
13.02.25
€163.54
13.02.26
13.02.26
6.50%
14.02.26
14.02.26